| Bioactivity | Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B (HBV).. |
| Name | Xalnesiran sodium |
| CAS | 2538784-49-3 |
| Formula | C664H814F17N231Na57O415P57S6 |
| Molar Mass | 22262.12 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Information, Vol. 35, No. 4, 2021 |